BTW
Boston Trust Walden Portfolio holdings
AUM
$14B
1-Year Return
12.58%
This Quarter Return
+4.28%
1 Year Return
+12.58%
3 Year Return
+52.97%
5 Year Return
+115.22%
10 Year Return
+284.47%
AUM
$12.2B
AUM Growth
+$607M
(+5.2%)
Cap. Flow
+$211M
Cap. Flow
% of AUM
1.73%
Top 10 Holdings %
Top 10 Hldgs %
18.81%
Holding
373
New
8
Increased
169
Reduced
123
Closed
6
Top Buys
| 1 |
Qualys
QLYS
|
$45.6M |
| 2 |
Jones Lang LaSalle
JLL
|
$35.7M |
| 3 |
Waters Corp
WAT
|
$35.2M |
| 4 |
Sprouts Farmers Market
SFM
|
$35.1M |
| 5 |
Northern Trust
NTRS
|
$29.7M |
Top Sells
| 1 |
Lamb Weston
LW
|
$22.2M |
| 2 |
Cavco Industries
CVCO
|
$20.4M |
| 3 |
Omnicom Group
OMC
|
$18.1M |
| 4 |
Lincoln Electric
LECO
|
$17.8M |
| 5 |
Microsoft
MSFT
|
$17.6M |
Sector Composition
| 1 | Technology | 21.92% |
| 2 | Healthcare | 16.83% |
| 3 | Industrials | 15.22% |
| 4 | Financials | 13.45% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cabot Corp
CBT
$4.31B
| $593K | ﹤0.01% |
8,859
| – | – |
|
302
GE Aerospace
GE
$297B
| $588K | ﹤0.01% |
6,706
-29
| -0.4% | -$2.54K |
|
303
Sensata Technologies
ST
$4.66B
| $586K | ﹤0.01% |
13,036
-2,460
| -16% | -$111K |
|
304
Dimensional US Core Equity 2 ETF
DFAC
$37.3B
| $585K | ﹤0.01% |
21,537
| – | – |
|
305
Wells Fargo
WFC
$253B
| $577K | ﹤0.01% |
13,515
-703
| -5% | -$30K |
|
306
Eaton
ETN
$136B
| $574K | ﹤0.01% |
2,854
+155
| +6% | +$31.2K |
|
307
Carrier Global
CARR
$55.8B
| $544K | ﹤0.01% |
10,937
| – | – |
|
308
HCA Healthcare
HCA
$98.4B
| $537K | ﹤0.01% |
1,768
| – | – |
|
309
Truist Financial
TFC
$60B
| $526K | ﹤0.01% |
17,337
-481
| -3% | -$14.6K |
|
310
iShares MSCI USA Quality Factor ETF
QUAL
$54.2B
| $518K | ﹤0.01% |
3,840
| – | – |
|
311
Invesco QQQ Trust
QQQ
$368B
| $506K | ﹤0.01% |
1,371
+44
| +3% | +$16.3K |
|
312
IBM
IBM
$231B
| $500K | ﹤0.01% |
3,737
-330
| -8% | -$44.2K |
|
313
Autoliv
ALV
$9.57B
| $499K | ﹤0.01% |
5,865
-840
| -13% | -$71.4K |
|
314
Prologis
PLD
$105B
| $489K | ﹤0.01% |
3,990
| – | – |
|
315
Sherwin-Williams
SHW
$92.9B
| $487K | ﹤0.01% |
1,833
| – | – |
|
316
Salesforce
CRM
$238B
| $486K | ﹤0.01% |
2,302
-109
| -5% | -$23K |
|
317
Unilever
UL
$158B
| $469K | ﹤0.01% |
9,005
| – | – |
|
318
Vanguard FTSE All-World ex-US ETF
VEU
$48.8B
| $458K | ﹤0.01% |
8,411
| – | – |
|
319
Vanguard Total World Stock ETF
VT
$51.8B
| $410K | ﹤0.01% |
4,225
| – | – |
|
320
Vertex Pharmaceuticals
VRTX
$101B
| $391K | ﹤0.01% |
1,110
| – | – |
|
321
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $387K | ﹤0.01% |
8,376
+2,800
| +50% | +$129K |
|
322
AstraZeneca
AZN
$253B
| $386K | ﹤0.01% |
5,400
| – | – |
|
323
Otis Worldwide
OTIS
$34.1B
| $378K | ﹤0.01% |
4,248
| – | – |
|
324
Vanguard Real Estate ETF
VNQ
$34.7B
| $378K | ﹤0.01% |
4,522
-500
| -10% | -$41.8K |
|
325
Charles Schwab
SCHW
$167B
| $373K | ﹤0.01% |
6,579
-1,330
| -17% | -$75.4K |
|